Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126083 · ClinicalTrials.gov registry record · Phase 4
Lofexidine for Adults Undergoing Lumbar Spine Surgery
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT04126083: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT04126083 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04126083, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The primary objective is to investigate the effects of lofexidine in adults undergoing opioid tapering prior to elective lumbar spine surgery.
Interventions
- DRUG Lofexidine Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2021-04-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04126083
The ClinicalTrials.gov registry entry for NCT04126083 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lofexidine Oral Tablet is the first listed.
NCT04126083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04126083 about?
NCT04126083 is a clinical study titled "Lofexidine for Adults Undergoing Lumbar Spine Surgery". The primary objective is to investigate the effects of lofexidine in adults undergoing opioid tapering prior to elective lumbar spine surgery.
What is the current status of trial NCT04126083?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2019-09-01. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT04126083?
The interventions under investigation include: Lofexidine Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT04126083?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.